Endologix Announces Release Date for Third Quarter 2016 Financial Results and Details of 2016 Investor Meeting
October 24, 2016 09:00 ET
|
Endologix
IRVINE, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...
Endologix Reports Positive Clinical Data from Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
September 20, 2016 12:10 ET
|
Endologix
IRVINE, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from...
Endologix to Participate in Two Investor Conferences in September 2016
September 06, 2016 09:00 ET
|
Endologix
IRVINE, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Endologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System
August 17, 2016 09:00 ET
|
Endologix
IRVINE, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first two patients...
Endologix to Present at the 36th Annual Canaccord Genuity Growth Conference
August 04, 2016 16:00 ET
|
Endologix
IRVINE, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the 36th...
Endologix Reports Results for the Second Quarter 2016
August 02, 2016 16:05 ET
|
Endologix
IRVINE, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
Endologix to Report Second Quarter 2016 Financial Results on August 2, 2016
July 12, 2016 09:00 ET
|
Endologix
IRVINE, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...
Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
June 09, 2016 09:33 ET
|
Endologix
IRVINE, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the...
Endologix to Present at Jefferies Healthcare Conference
June 03, 2016 09:00 ET
|
Endologix
IRVINE, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the...
Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
May 26, 2016 09:00 ET
|
Endologix
IRVINE, Calif., May 26, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from...